DNS-3379 vs. Placebo in Stroke Rehabilitation "SPIRIT"


Phase 2 Results N/A

Summary of Purpose

This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 November 2017.

13 Nov 2017 14 Aug 2017 30 Nov 2018 30 Nov 2018 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

Not available